A greater understanding of cancer biology combined with technological advancements allows us to deliver industry-leading diagnostics.
Progress in cancer treatment has been made through molecular analysis and biomarker discovery. Major breakthroughs have transformed several aspects of screening strategies and clinician care for treatment decisions. Cancer treatment has evolved from broad chemotherapy to targeted therapy and immunotherapies. Additionally, innovative technologies such as next-generation sequencing, liquid biopsies and artificial intelligence-powered image analysis algorithms are facilitating evolution in personalised healthcare. These advances have changed the natural course of disease for millions of patients.
Our long-term vision is to help prevent or cure this disease in all its forms, and our scientific rigour, the pipeline of innovative therapies and passion for progress will continue to aid in the advancement of cancer care in the years ahead.
Oncology Disease Area Lead
Combining a patient-centric approach with deep business acumen in the oncology disease area, Derek has a passion for education and patient advocacy. His focus is on improving outcomes by providing integrative solutions that make a difference in the lives of patients and their families. With over 20 years of experience in the oncology space, improving the knowledge and capability of our specialist physicians, GPs, Nurses and Pharmacists is a focus for Derek in his role as Oncology Disease Area Lead at Roche Diagnostics Australia.
This page is provided as a contact service and does not replace the advice of a physician. Roche cannot respond to questions about general medical information or questions regarding your personal medical condition. Medications and diagnostics products can not be directly ordered through this website. Please note that we do not respond to form letters or e-mail campaigns.
09441751001_00000000_02
